Accuray appoints medtech veteran as chief commercial officer
The intensive Stupp protocol shows promise in new research
Read about AHRQ research on IMRT.
Many of the 465 kids treated with proton therapy have central nervous system cancers.
Lowers number of uninsured patients
Little is known about the effects of low-dose radiation
Insights from Catherine Ofori-Atta, senior clinical operations lead at Roche and Sandra Amaro, head of clinical trial diversity at Pfizer
Insights from Paul Frisch, chief of biomedical physics & engineering at Memorial Sloan Kettering Cancer Institute
The P-CURE solution.
South Korea wants to become a "radiation vacation" destination.
New study paves way for a potential application.
Set to close a $25 million funding round
Yes, but challenges remain.
Two-thirds of PET providers anticipate procedure volumes will increase over next 12 months
Some of the products and services you won't want to miss on the exhibit floor
The latest in a string of health care activities from the company
Varian appoints VP of clinical affairs
Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), has entered into an agreement with the Department of Radiation Oncology at the Washington University in St. Louis School of Medicine to embark on a Cooperative Quality Assurance Project.
The Radiance 330 is a compact delivery system.
The nation's first radiation therapists gain certificates for an advanced cancer treatment technique.